Can a delicate cornea transplant work after other eye surgeries?
NCT ID NCT06013462
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how safe and effective DMEK (a type of cornea transplant) is for people who have already had eye surgeries like vitrectomy or glaucoma surgery. Researchers will track serious complications and vision improvement over 12 months in 80 participants. The goal is to see if DMEK can be a good option even in these more challenging cases.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Descemet Membrane Endothelial Keratoplasty (DMEK) surgery
- What this could lead to
- If successful, this study could show that DMEK surgery is safe and effective even for patients with complicated eye histories, potentially improving vision outcomes for this group.
- What could go wrong
- This is an observational study with only 80 participants, so results may not apply to everyone. The surgery itself carries risks like graft detachment or rejection, especially in these complex cases.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORNEAL ENDOTHELIAL DECOMPENSATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fondation Ophtalmologique A de Rothschild
RECRUITINGParis, 75019, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.